Vge Iii Portfolio Ltd. - Net Worth and Insider Trading
Vge Iii Portfolio Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vge Iii Portfolio Ltd. owns 8 companies in total, including Arbutus Biopharma Corp (ABUS) , Sio Gene Therapies Inc (SIOX) , and Myovant Sciences Ltd (MYOV) among others .
Click here to see the complete history of Vge Iii Portfolio Ltd.’s form 4 insider trades.
Insider Ownership Summary of Vge Iii Portfolio Ltd.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ABUS | Arbutus Biopharma Corp | 2016-07-08 | 10 percent owner |
SIOX | Sio Gene Therapies Inc | 2016-07-08 | 10 percent owner |
MYOV | Myovant Sciences Ltd | 2016-10-26 | 10 percent owner |
2019-07-10 | other: Former 10% Owner | ||
2019-06-26 | 10 percent owner | ||
2016-04-13 | 10 percent owner | ||
2016-02-08 | 10 percent owner | ||
2014-10-01 | 10 percent owner |
Vge Iii Portfolio Ltd. Trading Performance
Vge Iii Portfolio Ltd. Ownership Network
Ownership Network List of Vge Iii Portfolio Ltd.
Ownership Network Relation of Vge Iii Portfolio Ltd.
Vge Iii Portfolio Ltd. Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Vge Iii Portfolio Ltd. is the 10 percent owner of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Vge Iii Portfolio Ltd. made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Vge Iii Portfolio Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Vge Iii Portfolio Ltd.. You might contact Vge Iii Portfolio Ltd. via mailing address: C/o Morgan Stanley Fund Srvcs (cayman), Cricket Sq, Hutchins Dr, Po Box 2681, Grand Cayman E9 Ky1-1111.